Single-Use Bioreactors: Powering the Growth of the Biologics Industry
The biologics industry is at the forefront of medical innovation, driving breakthroughs in vaccines, monoclonal antibodies, cell and gene therapies, and recombinant proteins. As demand for biologics continues to surge, the need for flexible, scalable, and cost-efficient manufacturing systems has become more pressing than ever. Enter the single-use bioreactor (SUB) — a technology that is...